Attendo AB (publ) (ATT.ST)
SEK 51.8
(1.77%)
SEK 51.8
(1.77%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.28 Billion SEK | 19.25% |
| 2022 | 14.49 Billion SEK | 12.66% |
| 2021 | 12.86 Billion SEK | 4.71% |
| 2020 | 12.28 Billion SEK | 2.96% |
| 2019 | 11.93 Billion SEK | 8.63% |
| 2018 | 10.98 Billion SEK | -1.52% |
| 2017 | 11.15 Billion SEK | 9.25% |
| 2016 | 10.21 Billion SEK | 3.88% |
| 2015 | 9.83 Billion SEK | 8.69% |
| 2014 | 9.04 Billion SEK | 6.85% |
| 2013 | 8.46 Billion SEK | 7.28% |
| 2012 | 7.89 Billion SEK | 8.25% |
| 2011 | 7.28 Billion SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.84 Billion SEK | 10.37% |
| 2024 Q3 | 4.87 Billion SEK | 0.7% |
| 2024 Q1 | 4.38 Billion SEK | -0.81% |
| 2023 Q2 | 4.33 Billion SEK | 7.15% |
| 2023 Q1 | 4.04 Billion SEK | 6.73% |
| 2023 Q3 | 4.48 Billion SEK | 3.58% |
| 2023 FY | 17.28 Billion SEK | 19.25% |
| 2023 Q4 | 4.42 Billion SEK | -1.47% |
| 2022 FY | 14.49 Billion SEK | 12.66% |
| 2022 Q4 | 3.78 Billion SEK | 2.99% |
| 2022 Q3 | 3.67 Billion SEK | 3.75% |
| 2022 Q2 | 3.54 Billion SEK | 1.84% |
| 2022 Q1 | 3.48 Billion SEK | 4.31% |
| 2021 Q1 | 3.06 Billion SEK | -0.1% |
| 2021 Q2 | 3.2 Billion SEK | 4.74% |
| 2021 Q3 | 3.26 Billion SEK | 1.65% |
| 2021 Q4 | 3.33 Billion SEK | 2.39% |
| 2021 FY | 12.86 Billion SEK | 4.71% |
| 2020 Q3 | 2.98 Billion SEK | -4.15% |
| 2020 Q4 | 3.06 Billion SEK | 2.75% |
| 2020 FY | 12.28 Billion SEK | 2.96% |
| 2020 Q1 | 3.12 Billion SEK | 2.42% |
| 2020 Q2 | 3.11 Billion SEK | -0.51% |
| 2019 Q1 | 2.87 Billion SEK | 2.13% |
| 2019 Q2 | 2.99 Billion SEK | 3.89% |
| 2019 Q3 | 3.01 Billion SEK | 0.77% |
| 2019 FY | 11.93 Billion SEK | 8.63% |
| 2019 Q4 | 3.05 Billion SEK | 1.36% |
| 2018 FY | 10.98 Billion SEK | -1.52% |
| 2018 Q4 | 2.81 Billion SEK | 0.57% |
| 2018 Q3 | 2.8 Billion SEK | 2.15% |
| 2018 Q2 | 2.74 Billion SEK | -14.28% |
| 2018 Q1 | 3.2 Billion SEK | 6.28% |
| 2017 Q2 | 2.74 Billion SEK | 3.12% |
| 2017 FY | 11.15 Billion SEK | 9.25% |
| 2017 Q3 | 2.74 Billion SEK | -0.11% |
| 2017 Q4 | 3.01 Billion SEK | 9.85% |
| 2017 Q1 | 2.66 Billion SEK | 0.53% |
| 2016 Q1 | 2.47 Billion SEK | -3.59% |
| 2016 FY | 10.21 Billion SEK | 3.88% |
| 2016 Q3 | 2.56 Billion SEK | 1.7% |
| 2016 Q2 | 2.52 Billion SEK | 2.14% |
| 2016 Q4 | 2.64 Billion SEK | 3.08% |
| 2015 FY | 9.83 Billion SEK | 8.69% |
| 2015 Q4 | 2.56 Billion SEK | 4.44% |
| 2015 Q1 | 2.39 Billion SEK | 3.24% |
| 2015 Q2 | 2.42 Billion SEK | 1.25% |
| 2015 Q3 | 2.45 Billion SEK | 1.4% |
| 2014 Q3 | 2.28 Billion SEK | 0.0% |
| 2014 FY | 9.04 Billion SEK | 6.85% |
| 2014 Q4 | 2.31 Billion SEK | 1.49% |
| 2013 FY | 8.46 Billion SEK | 7.28% |
| 2012 FY | 7.89 Billion SEK | 8.25% |
| 2011 FY | 7.28 Billion SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ambea AB (publ) | 13.31 Billion SEK | -29.86% |
| Humana AB (publ) | 9.64 Billion SEK | -79.158% |
| ProstaLund AB (publ) | 22.2 Million SEK | -77748.329% |